Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
35.63
+0.04 (0.11%)
At close: Dec 20, 2024, 4:00 PM
35.50
-0.13 (-0.36%)
After-hours: Dec 20, 2024, 6:32 PM EST
Ionis Pharmaceuticals Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for IONS stock have an average target of 62, with a low estimate of 37 and a high estimate of 77. The average target predicts an increase of 74.01% from the current stock price of 35.63.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for IONS stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 6 | 6 | 6 | 6 | 7 | 7 |
| Hold | 4 | 6 | 6 | 6 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 16 | 18 | 18 | 18 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | +68.40% | Dec 20, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $65 → $62 | Buy | Maintains | $65 → $62 | +74.01% | Nov 14, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $82 → $77 | Buy | Maintains | $82 → $77 | +116.11% | Nov 7, 2024 |
| Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +68.40% | Nov 7, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $70 → $65 | Strong Buy | Maintains | $70 → $65 | +82.43% | Oct 9, 2024 |
Financial Forecast
Revenue This Year
634.69M
from 787.65M
Decreased by -19.42%
Revenue Next Year
750.58M
from 634.69M
Increased by 18.26%
EPS This Year
-3.49
from -2.56
EPS Next Year
-3.69
from -3.49
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 711.5M | 1.3B | 1.6B | |||
| Avg | 634.7M | 750.6M | 935.5M | |||
| Low | 584.1M | 423.8M | 627.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -9.7% | 103.4% | 109.7% | |||
| Avg | -19.4% | 18.3% | 24.6% | |||
| Low | -25.8% | -33.2% | -16.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -3.19 | -2.25 | -1.38 | |||
| Avg | -3.49 | -3.69 | -2.83 | |||
| Low | -3.66 | -5.07 | -4.15 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.